Lipid nanoparticles: nanocarriers for more effective and safer photoprotective products

References

• CE. Cosmetics directive. European Council Directive 76/768/EEC (1976).
   Google Scholar
• Janjua NR, Kongshoj B, Petersen JH, Wulf HC. Sunscreens and thyroid function in humans after short-term whole-body topical application: a single-blinded study. Br. J. Dermatol.156(5), 1080–1082 (2007).
   PubMed Web of Science ®Google Scholar
• Janjua NR, Kongshoj B, Andersson AM, Wulf HC. Sunscreens in human plasma and urine after repeated whole-body topical application. J. Eur. Acad. Dermatol. Venereol.22(4), 456–461 (2008).
   PubMed Web of Science ®Google Scholar
• Schlumpf M, Durrer S, Faass O et al. Developmental toxicity of UV filters and environmental exposure: a review. Int. J. Androl.31(2), 144–151 (2008).
   PubMed Web of Science ®Google Scholar
• Schlumpf M, Schmid P, Durrer S et al. Endocrine activity and developmental toxicity of cosmetic UV filters-an update. Toxicology205(1–2), 113–122 (2004).
   PubMed Web of Science ®Google Scholar
• Scheuer E, Warshaw E. Sunscreen allergy: areview of epidemiology, clinical characteristics, and responsible allergens. Dermatitis17(1), 3–11 (2006).
   PubMed Web of Science ®Google Scholar
• Lindberg M, Tammela M, Bostrom A et al. Are adverse skin reactions to cosmetics underestimated in the clinical assessment of contact dermatitis?. A prospective study among 1075 patients attending Swedish patch test clinics. Acta Derm. Venereol.84(4), 291–295 (2004).
   PubMed Web of Science ®Google Scholar
• Lautenschlager S, Wulf HC, Pittelkow MR. Photoprotection. Lancet370(9586), 528–537 (2007).
   PubMed Web of Science ®Google Scholar
• Weiss B. Can endocrine disruptors influence neuroplasticity in the aging brain?. Neurotoxicology28(5), 938–950 (2007).
   PubMed Web of Science ®Google Scholar
• Nashev LG, Schuster D, Laggner C et al. The UV-filter benzophenone-1 inhibits 17β-hydroxysteroid dehydrogenase type 3: virtual screening as a strategy to identify potential endocrine disrupting chemicals. Biochem. Pharmacol.79(8), 1189–1199 (2010).
   PubMed Web of Science ®Google Scholar
• Kunz PY, Fent K. Estrogenic activity of UV filter mixtures. Toxicol. Appl. Pharmacol.217(1), 86–99 (2006).
   PubMed Web of Science ®Google Scholar
• Kunz PY, Fent K. Multiple hormonal activities of UV filters and comparison of in vivo and in vitro estrogenic activity of ethyl-4-aminobenzoate in fish. Aquat. Toxicol.79(4), 305–324 (2006).
   PubMed Web of Science ®Google Scholar
• Balmer ME, Buser HR, Muller MD, Poiger T. Occurrence of some organic UV filters in wastewater, in surface waters, and in fish from Swiss Lakes. Environ. Sci. Technol.39(4), 953–962 (2005).
   PubMed Web of Science ®Google Scholar
• Fent K, Zenker A, Rapp M. Widespread occurrence of estrogenic UV-filters in aquatic ecosystems in Switzerland. Environ. Pollut.158(5), 1817–1824 (2010).
   PubMed Web of Science ®Google Scholar
• Nikolic S, Keck CM, Anselmi C, Muller RH. Skin photoprotection improvement: synergistic interaction between lipid nanoparticles and organic UV filters. Int. J. Pharm.414(1–2), 276–284 (2011).
   PubMed Web of Science ®Google Scholar
• Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles (SLN). J. Microencapsul.18(2), 149–158 (2001).
   PubMed Web of Science ®Google Scholar
• Xia Q, Saupe A, Muller RH, Souto EB. Nanostructured lipid carriers as novel carrier for sunscreen formulations. Int. J. Cosmet. Sci.29(6), 473–482 (2007).
   PubMed Web of Science ®Google Scholar
• US FDA. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use. Final rule. Fed. Regis.76(117), 35620–35665 (2011).
   PubMedGoogle Scholar
• Wissing SA, Muller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J. Control. Release81(3), 225–233 (2002).
   PubMed Web of Science ®Google Scholar
• Gasco MR. Lipid nanoparticles: perspectives and challenges. Adv. Drug Deliv. Rev.59(6), 377–378 (2007).
   PubMed Web of Science ®Google Scholar
• Kalam MA, Sultana Y, Ali A, Aqil M, Mishra AK, Chuttani K. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. J. Drug Target.18(3), 191–204 (2010).
   PubMed Web of Science ®Google Scholar
• Ma P, Dong X, Swadley CL et al. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. J. Biomed. Nanotechnol.5(2), 151–161 (2009).
   PubMed Web of Science ®Google Scholar
• Parhi R, Suresh P. Production of solid lipid nanoparticles–drug loading and release mechanism. J. Chem. Pharm. Res.2(1), 211 (2010).
   Google Scholar
• Wissing SA, Muller RH. Solid lipid nanoparticles (SLN) – a novel carrier for UV blockers. Pharmazie56(10), 783–786 (2001).
   PubMed Web of Science ®Google Scholar
• Wissing SA, Muller RH. A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles. Int. J. Cosmet. Sci.23(4), 233–243 (2001).
   PubMedGoogle Scholar
• Gulbake A, Jain A, Khare P, Jain SK. Solid lipid nanoparticles bearing oxybenzone: in vitro and in vivo evaluation. J. Microencapsul.27(3), 226–233 (2010).
   PubMed Web of Science ®Google Scholar
• Marcato PD, Caverzan J, Rossi-Bergmann B et al. Nanostructured polymer and lipid carriers for sunscreen. Biological effects and skin permeation. J. Nanosci. Nanotechnol.11(3), 1880–1886 (2011).
   PubMed Web of Science ®Google Scholar
• Nesseem D. Formulation of sunscreens with enhancement sun protection factor response based on solid lipid nanoparticles. Int. J. Cosmet. Sci.33(1), 70–79 (2011).
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Muller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm.366(1–2), 170–184 (2009).
   PubMed Web of Science ®Google Scholar
• SCENIHR. Opinion on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. European Commission Health & Consumer Protection Directorate-General 1–79 (2005).
   Google Scholar
• Schilling K, Bradford B, Castelli D et al. Human safety review of ‘nano’ titanium dioxide and zinc oxide. Photochem. Photobiol. Sci.9(4), 495–509 (2010).
   PubMed Web of Science ®Google Scholar
• Villalobos-Hernandez JR, Muller-Goymann CC. In vitro erythemal UV-A protection factors of inorganic sunscreens distributed in aqueous media using carnauba wax-decyl oleate nanoparticles. Eur. J. Pharm. Biopharm.65(1), 122–125 (2007).
   PubMed Web of Science ®Google Scholar
• Villalobos-Hernandez JR, Muller-Goymann CC. Sun protection enhancement of titanium dioxide crystals by the use of carnauba wax nanoparticles: the synergistic interaction between organic and inorganic sunscreens at nanoscale. Int. J. Pharm.322(1–2), 161–170 (2006).
   PubMed Web of Science ®Google Scholar
• Villalobos-Hernandez JR, Muller-Goymann CC. Physical stability, centrifugation tests, and entrapment efficiency studies of carnauba wax-decyl oleate nanoparticles used for the dispersion of inorganic sunscreens in aqueous media. Eur. J. Pharm. Biopharm.63(2), 115–127 (2006).
   PubMed Web of Science ®Google Scholar
• Villalobos-Hernandez JR, Muller-Goymann CC. In vitro erythemal UV-A protection factors of inorganic sunscreens distributed in aqueous media using carnauba wax-decyl oleate nanoparticles. Eur. J. Pharm. Biopharm.65(1), 122–125 (2007).
   PubMed Web of Science ®Google Scholar
• Lippacher A, Muller RH, Mader K. Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. Int. J. Pharm.214(1–2), 9–12 (2001).
   PubMed Web of Science ®Google Scholar
• Prabaharan M. Review paper: chitosan derivatives as promising materials for controlled drug delivery. J. Biomater. Appl.23(1), 5–36 (2008).
   PubMed Web of Science ®Google Scholar
• Pople PV, Singh KK. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSciTech7(4), 91 (2006).
   PubMed Web of Science ®Google Scholar
• Paolicelli P, Cerreto F, Cesa S et al. Influence of the formulation components on the properties of the system SLN-dextran hydrogel for the modified release of drugs. J. Microencapsul.26(4), 355–364 (2009).
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. Pharmazie61(5), 431–437 (2006).
   PubMed Web of Science ®Google Scholar
• Jenning V, Schafer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Control Release66(2–3), 115–126 (2000).
   PubMed Web of Science ®Google Scholar